Testing of compounds versus wild-type kinases from reaction biology corporation:1186704 [19-001667]
Ended Purchase Order Awarded
- Contract number
- 75N95019P00203
- Awardee
-
Reaction Biology Corporation UEI LDBCLKM4WJH1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $102,100
Award facts
- Opportunity
-
- Testing of compounds for inhibition of 50 and 374 wild-type kinase enzymes Pre-Solicitation · 75N95019Q00073 · Posted Jan 30, 2019
- Testing of compounds for inhibition of 50 and 374 wild-type kinase enzymes Pre-Solicitation · Posted Feb 21, 2019
- Contract value 100% obligated
- $102,100.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Malvern, PA 19355, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Reaction Biology Corporation, a self-certified small disadvantaged business. The $102,100 contract is for testing 10 novel small molecule compounds against a panel of 50 wild-type kinases, as well as testing 5 compounds against a more comprehensive panel of 374 wild-type kinases. The purpose is to assess the kinase inhibitory activity of these compounds, which are being developed as potential treatments for cancers like acute myeloid leukemia and myelodysplastic syndromes. The contract utilizes the Kinase HotSpot assay platform to conduct this specialized scientific testing. No small business set-aside was used for this award.
Quick answers
Who was awarded contract 75N95019P00203?
75N95019P00203 was awarded to Reaction Biology Corporation by National Institute on Drug Abuse (National Institutes of Health) on March 13, 2019.
How much is contract 75N95019P00203 worth?
The government has obligated $102,100 on 75N95019P00203.
Was contract 75N95019P00203 competed?
The extent of competition for 75N95019P00203 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award